|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | G01N 33/569 | (2006.01) |
| A61P 1/04 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3575792 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19169482.7 |
| Date of filing the European patent application | 2012-05-31 | |
| (97) | Date of publication of the European application | 2019-12-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-30 |
| (46) | Date of publication of the claims translation | 2023-03-10 |
| (30) | Number | Date | Country code |
| 201161491810 P | 2011-05-31 | US | |
| 201161508584 P | 2011-07-15 | US | |
| 201161550257 P | 2011-10-21 | US | |
| 201261636588 P | 2012-04-20 | US |
| (72) |
SUBRAMANYAM, Meena , US
PLAVINA, Tatiana , US
BLOOMGREN, Gary, Lewis , US
BOZIC, Carmen , US
LEE, Sophia , US
|
| (73) |
Biogen MA Inc. ,
225 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PDL rizikos vertinimo būdas |
| METHOD OF ASSESSING RISK OF PML |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2026-02-18 |